175 related articles for article (PubMed ID: 20193064)
1. Trends in the incidence and survival of multiple myeloma in South East England 1985-2004.
Renshaw C; Ketley N; Møller H; Davies EA
BMC Cancer; 2010 Mar; 10():74. PubMed ID: 20193064
[TBL] [Abstract][Full Text] [Related]
2. Multiple myeloma in north east Scotland: a review of incidence and survival over three decades.
Soutar RL; Dawson AA; Wilson BJ
Health Bull (Edinb); 1996 May; 54(3):232-40. PubMed ID: 8707567
[TBL] [Abstract][Full Text] [Related]
3. Histological subtype of lung cancer in relation to socio-economic deprivation in South East England.
Bennett VA; Davies EA; Jack RH; Mak V; Møller H
BMC Cancer; 2008 May; 8():139. PubMed ID: 18489782
[TBL] [Abstract][Full Text] [Related]
4. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
5. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
6. Trends in the incidence and survival of cancer in teenagers and young adults: regional analysis for South East England 1960-2002.
Croucher C; Whelan JS; Møller H; Davies EA
Clin Oncol (R Coll Radiol); 2009 Jun; 21(5):417-24. PubMed ID: 19375901
[TBL] [Abstract][Full Text] [Related]
7. The epidemiology and treatment of mesothelioma in South East England 1985-2002.
Mak V; Davies E; Putcha V; Choodari-Oskooei B; Møller H
Thorax; 2008 Feb; 63(2):160-6. PubMed ID: 17675318
[TBL] [Abstract][Full Text] [Related]
8. A 20-year retrospective study of tonsil cancer incidence and survival trends in South East England: 1987-2006.
Olaleye O; Moorthy R; Lyne O; Black M; Mitchell D; Wiseberg J
Clin Otolaryngol; 2011 Aug; 36(4):325-35. PubMed ID: 21696555
[TBL] [Abstract][Full Text] [Related]
9. Variation in incidence and survival by ethnicity for patients with myeloma in England (2002-2008).
Samy EF; Ross J; Bolton E; Morris EJ; Oliver SE
Leuk Lymphoma; 2015; 56(9):2660-7. PubMed ID: 25651425
[TBL] [Abstract][Full Text] [Related]
10. Trends of incidence, mortality and survival of multiple myeloma in Spain. A twenty-three-year population-based study.
Chang-Chan DY; Ríos-Tamayo R; Rodríguez Barranco M; Redondo-Sánchez D; González Y; Marcos-Gragera R; Sánchez MJ
Clin Transl Oncol; 2021 Jul; 23(7):1429-1439. PubMed ID: 33433836
[TBL] [Abstract][Full Text] [Related]
11. Trends of incidence, mortality, and survival of multiple myeloma in Switzerland between 1994 and 2013.
Andres M; Feller A; Arndt V;
Cancer Epidemiol; 2018 Apr; 53():105-110. PubMed ID: 29414629
[TBL] [Abstract][Full Text] [Related]
12. Outcome and survival of myeloma patients diagnosed 2008-2015. Real-world data on 4904 patients from the Swedish Myeloma Registry.
Blimark CH; Turesson I; Genell A; Ahlberg L; Björkstrand B; Carlson K; Forsberg K; Juliusson G; Linder O; Mellqvist UH; Nahi H; Kristinsson SY;
Haematologica; 2018 Mar; 103(3):506-513. PubMed ID: 29217784
[TBL] [Abstract][Full Text] [Related]
13. Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
Milano AF
J Insur Med; 2018; 47(4):203-211. PubMed ID: 30668210
[TBL] [Abstract][Full Text] [Related]
14. Impact of age, sex, ethnicity, socio-economic deprivation and novel pharmaceuticals on the overall survival of patients with multiple myeloma in New Zealand.
Chan HSH; Milne RJ
Br J Haematol; 2020 Mar; 188(5):692-700. PubMed ID: 31584720
[TBL] [Abstract][Full Text] [Related]
15. Trends in survival of multiple myeloma patients in Germany and the United States in the first decade of the 21st century.
Pulte D; Jansen L; Castro FA; Emrich K; Katalinic A; Holleczek B; Brenner H;
Br J Haematol; 2015 Oct; 171(2):189-196. PubMed ID: 26123295
[TBL] [Abstract][Full Text] [Related]
16. Age disparities in survival from lymphoma and myeloma: a comparison between US and England.
Pulte D; Redaniel MT; Lowry L; Bird J; Jeffreys M
Br J Haematol; 2014 Jun; 165(6):824-31. PubMed ID: 24684252
[TBL] [Abstract][Full Text] [Related]
17. Leukemias, myeloma, and other lymphoreticular neoplasms.
Hernández JA; Land KJ; McKenna RW
Cancer; 1995 Jan; 75(1 Suppl):381-94. PubMed ID: 8001009
[TBL] [Abstract][Full Text] [Related]
18. The epidemiological landscape of multiple myeloma: a global cancer registry estimate of disease burden, risk factors, and temporal trends.
Huang J; Chan SC; Lok V; Zhang L; Lucero-Prisno DE; Xu W; Zheng ZJ; Elcarte E; Withers M; Wong MCS;
Lancet Haematol; 2022 Sep; 9(9):e670-e677. PubMed ID: 35843248
[TBL] [Abstract][Full Text] [Related]
19. A population study to define the incidence and survival of multiple myeloma in a National Health Service Region in UK.
Phekoo KJ; Schey SA; Richards MA; Bevan DH; Bell S; Gillett D; Møller H;
Br J Haematol; 2004 Nov; 127(3):299-304. PubMed ID: 15491289
[TBL] [Abstract][Full Text] [Related]
20. Trends in myeloma incidence, mortality and survival in New Zealand (1985-2016).
Sneyd MJ; Cox B; Morison IM
Cancer Epidemiol; 2019 Jun; 60():55-59. PubMed ID: 30921701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
